2023-04-06 ワシントン大学セントルイス校
研究チームは、COVID-19の合併症リスクを早期に診断するため、高スループットプロテオミクス法を使用しました。研究結果は「iScience」誌にオンラインで掲載されています。
<関連情報>
- https://medicine.wustl.edu/news/covid-19-patients-blood-plasma-shows-who-is-most-likely-to-become-severely-ill/
- https://www.sciencedirect.com/science/article/pii/S2589004223004856
SARS-CoV-2感染と重症化の血漿プロテオミクスからアルツハイマー病と冠動脈疾患の病態に影響を与えることが判明 Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways
Lihua Wang, Daniel Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Joanne Norton, Pat Kohlfeld, John Budde, Sharlee Climer, Omar H. Butt, Daniel Jacobson, Michael Garvin, Alan R. Templeton, Shawn Campagna, Jane O’Halloran, Rachel Presti, Charles W. Goss, Philip A. Mudd, Beau M. Ances, Bin Zhang, Yun Ju Sung, Carlos Cruchaga
iScience Published: March 14, 2023
DOI:https://doi.org/10.1016/j.isci.2023.106408
Highlights
•1,449 plasma proteins are altered by COVID-19 infection, ventilation, or death
•Distinct prognostic models for ventilation and death after COVID-19 infection
•Altered proteins link to Alzheimer’s and coronary artery disease pathways
•Eight proteins are potentially causal for COVID-19 infection
Summary
Identification of proteins dysregulated by COVID-19 infection is critically important for better understanding of its pathophysiology, building prognostic models, and identifying new targets. Plasma proteomic profiling of 4,301 proteins was performed in two independent datasets and tested for the association for three COVID-19 outcomes (infection, ventilation, and death). We identified 1,449 proteins consistently associated in both datasets with any of these three outcomes. We subsequently created highly accurate models that distinctively predict infection, ventilation, and death. These proteins were enriched in specific biological processes including cytokine signaling, Alzheimer’s disease, and coronary artery disease. Mendelian randomization and gene network analyses identified eight causal proteins and 141 highly connected hub proteins including 35 with known drug targets. Our findings provide distinctive prognostic biomarkers for two severe COVID-19 outcomes, reveal their relationship to Alzheimer’s disease and coronary artery disease, and identify potential therapeutic targets for COVID-19 outcomes.
